The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 06, 2025

Filed:

Jun. 22, 2021
Applicant:

Procept Biorobotics Corporation, Redwood City, CA (US);

Inventors:

Nikolai Aljuri, Hillsborough, CA (US);

Surag Mantri, East Palo Alto, CA (US);

Rodney C. Perkins, Woodside, CA (US);

Assignee:

PROCEPT BioRobotics Corporation, San Jose, CA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 5/00 (2005.12); A61B 5/06 (2005.12); A61B 8/08 (2005.12); A61B 8/12 (2005.12); A61B 10/02 (2005.12); A61B 17/3203 (2005.12); A61B 18/00 (2005.12); A61B 18/04 (2005.12); A61B 18/12 (2005.12); A61B 18/14 (2005.12); A61B 18/16 (2005.12); A61B 18/22 (2005.12); A61B 90/00 (2015.12); A61M 25/00 (2005.12); A61M 25/04 (2005.12); A61M 25/10 (2012.12); A61N 5/10 (2005.12); G01N 33/574 (2005.12); A61B 17/00 (2005.12); A61B 90/50 (2015.12);
U.S. Cl.
CPC ...
A61N 5/1015 (2012.12); A61B 5/0071 (2012.12); A61B 5/0084 (2012.12); A61B 5/061 (2012.12); A61B 8/085 (2012.12); A61B 8/12 (2012.12); A61B 10/02 (2012.12); A61B 10/0241 (2012.12); A61B 10/0283 (2012.12); A61B 17/3203 (2012.12); A61B 17/32037 (2012.12); A61B 18/1206 (2012.12); A61B 18/1492 (2012.12); A61B 18/22 (2012.12); A61B 90/06 (2016.01); A61B 90/37 (2016.01); A61M 25/0017 (2012.12); A61M 25/10182 (2013.11); A61M 25/10185 (2013.11); A61N 5/1007 (2012.12); A61N 5/1027 (2012.12); G01N 33/57434 (2012.12); A61B 5/0073 (2012.12); A61B 2010/0225 (2012.12); A61B 2017/00274 (2012.12); A61B 2017/32032 (2012.12); A61B 2018/0022 (2012.12); A61B 2018/00547 (2012.12); A61B 2018/00577 (2012.12); A61B 2018/00595 (2012.12); A61B 2018/00863 (2012.12); A61B 2018/046 (2012.12); A61B 2018/1253 (2012.12); A61B 2018/126 (2012.12); A61B 18/16 (2012.12); A61B 2090/067 (2016.01); A61B 2090/378 (2016.01); A61B 2090/508 (2016.01); A61B 2217/005 (2012.12); A61B 2217/007 (2012.12); A61B 2218/002 (2012.12); A61B 2218/007 (2012.12); A61B 2505/05 (2012.12); A61B 2562/0219 (2012.12); A61M 2205/0216 (2012.12); A61M 2205/3334 (2012.12); A61M 2205/3344 (2012.12); A61M 2210/166 (2012.12); A61N 2005/1011 (2012.12); A61N 2005/1021 (2012.12); A61N 2005/1024 (2012.12); A61N 2005/1025 (2012.12); A61N 2005/1094 (2012.12);
Abstract

A catheter treatment apparatus comprises an elongate tubular member and an expandable support. The expandable support comprises a radioactive substance to treat cancerous tissue and is configured to expand from a narrow profile for insertion to a wide profile to engage and treat tissue remaining after resection. The expandable support can be sized to fit within a volume of removed tissue to place the radioactive substance in proximity to the capsule and remaining tissue, to spare the capsule and proximate nerves and vessels to treat tissue in proximity to the capsule. The elongate tubular member may comprise a channel such as a lumen to pass a bodily fluid such as urine when the expandable support engages the tissue to treat the patient for a plurality of days. The treatment apparatus can be used to resect and diagnose tissue concurrently. Based on the diagnosis, targeted segmental treatment may be given.


Find Patent Forward Citations

Loading…